Richard I Eisenstadt Insider Trading
Get free email notifications about insider trading for Richard I Eisenstadt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard I Eisenstadt. Richard I Eisenstadt is a VP, Finance & C.F.O. in Ocera Therapeutics, Inc. ($TZYM) and a Chief Financial Officer in AYTU BIOPHARMA, INC ($AYTU) and a Chief Financial Officer in Neos Therapeutics, Inc. ($NEOS).
Address: C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM 27703 NC
Companies in which Richard I Eisenstadt is an Insider
AYTU BIOPHARMA, INC
Trading Symbol: AYTUIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Eisenstadt: Chief Financial Officer
Holdings: 68,734 shares
Current Value: $61,173
Latest Transaction: Apr 05 2021
$AYTU Market Capitalization: $11.06M
$AYTU Previous Close: $0.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neos Therapeutics, Inc.
Trading Symbol: NEOSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Eisenstadt: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2021
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocera Therapeutics, Inc.
Trading Symbol: TZYMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Eisenstadt: VP, Finance & C.F.O.
Holdings: 0 shares
Latest Transaction: Apr 21 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Richard I Eisenstadt
Sentiment: All, AYTU, NEOS, TZYM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | AYTU | AYTU BIOPHARMA, IN ... | Eisenstadt Richard I | Chief Financial Off ... | Grant | A | 0.00 | 55,000 | 0 | 68,734 | 13.7 K to 68.7 K (+400.47 %) |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 1.49 | 115,000 | 171,350 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 2.31 | 230,276 | 531,938 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 8.30 | 56,250 | 466,875 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 7.00 | 45,000 | 315,000 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 10.74 | 50,000 | 537,000 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 25.50 | 60,230 | 1,535,865 | 0 |